Journals / Göztepe Tıp Dergisi / 2006 / Cilt: 21 - Sayı: 1

Subacute sclerosing panencephalitis

Subakut sklerozan panensefallit

Pages
20–22
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

On admission, ataxia and gait disorder was seen in 46 %, behavioral changes and disarthria 38 %, amnesia and head-drop 30 %, weakness, convulsions, headache and involuntary movements 23 %, urinary incontinence, myoclonic jerks, loss of consciousness 15 % and dysphagia 7.6 %.12 of the patients were treated with Isoprinosin and Interferon, 5 patients only Isoprinosin and 2 patients Interferon. 4 of them died approximately 7 months after diagnosis.This study is done to evaluate the clinical course of SSPE and to compare the results with literature knowledge.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Subacute sclerosing panencephalitis(SSPE) is a slow infection with measles virus that causes progressive inflammation and sclerosis of the brain.
📊
Key Findings & Data:It is the rarely seen late complication of measles, mostly occuring at 5-15 years of age.
💡
Conclusion & Impact:On admission, ataxia and gait disorder was seen in 46 %, behavioral changes and disarthria 38 %, amnesia and head-drop 30 %, weakness, convulsions, headache and involuntary movements 23 %, urinary incontinence, myoclonic jerks, loss of consciousness 15 % and dysphagia 7.6 %.12 of the patients were treated with Isoprinosin and Interferon, 5 patients only Isoprinosin and 2 patients Interferon. 4 of them died approximately 7 months after diagnosis.This study is done to evaluate the clinical course of SSPE and to compare the results with literature knowledge.
🔬Design:Research Article
📍Scope:2003 Verileri
⚙️Variables:Domain Parameters

Abstract

Subacute sclerosing panencephalitis(SSPE) is a slow infection with measles virus that causes progressive inflammation and sclerosis of the brain. It is the rarely seen late complication of measles, mostly occuring at 5-15 years of age. The incidence in males is twice as much as females. SSPE is neurodegenerative diseae which presents typically with changes in behaviour and progressive myoclonic activitiy followed by diffuse neurological disorsers. The disease is rapidly progressive and the survival time is approximately 6-24 months after the occurence of firts symptoms.In this study, 19 cases of SSPE, diagnosed and treated in our clinic between 1998-2003, are presented. 14 of the patients were male and 5 were female. Average was 6.3±2.5 years (2-10 years) and the mean age of measles infection was 1.3±0.9 years (3 months-2.5 years). 6 of the patients were unvaccinated. Most of the patients presented at stage 2. On admission, ataxia and gait disorder was seen in 46 %, behavioral changes and disarthria 38 %, amnesia and head-drop 30 %, weakness, convulsions, headache and involuntary movements 23 %, urinary incontinence, myoclonic jerks, loss of consciousness 15 % and dysphagia 7.6 %.12 of the patients were treated with Isoprinosin and Interferon, 5 patients only Isoprinosin and 2 patients Interferon. 4 of them died approximately 7 months after diagnosis.This study is done to evaluate the clinical course of SSPE and to compare the results with literature knowledge.

Özet

Subakut sklerozan panensefalit (SSPE), kızamık infeksiyonu geçirildikten yıllar sonra gelişen, ilerleyici inflamasyon ve sklerozla karakterize yavaş seyirli bir viral infeksiyondur. Ol-guların çoğunda başlangıç yaşı 5-15 yaş arasındadır ve erkeklerde kızlardan 2 kat fazla görülür. Hastalık tipik olarak kişilik değişikliği, ilerleyici miyoklonik aktiviteyle başlayan ve yaygın nörolojik bozukluklara yol açan, nörodejeneratif bir bozukluktur. Hastalık hızlı seyirli olup, semptomlar ortaya çıktıktan sonra 6-24 ay içinde ölüm görülür.Bu çalışmada, 1998-2003 yılları arasında kliniğimizde tanı konularak tedavileri düzenlenen toplam 19 SSPE olgusunu sunduk. Olgularımız 14 erkek, 5 kız olup, ortalama yaş 6.3± 2.5 yıl (2-10 yıl), kızamık infeksiyonunu geçirme yaşı 1.3±0.9 yıl (3 ay-2.5 yıl) olarak bulundu. Altı olguya aşı yapılmamıştı. İki olgunun ise aşı yapılıp yapılmadığı bilinmiyordu. Özellikle evre II'de gelen hastalarımızda; yürüyememe ve denge bozukluğu % 46, kişilik değişikliği ve konuşma bozukluğu % 38, unutkanlık ve başın öne düşmesi % 30, halsizlik, konvülziyon, baş ağrısı ve istemsiz hareket % 23, idrar kaçırma, sıçrama, bilinç kaybı % 15, yutma güçlüğü % 7.6 tesbit edildi. Oniki olguya isoprinosin ve interferon, 5 olguya isoprinosin, 2 olguya interferon tedavisi yapıldı. Dört olgu tanı aldıktan ortalama 7 ay sonra kaybedildi.SSPE'li olgularımızı literatür bilgisi altında değerlendirmek için bu çalışmayı sunduk.

🔖

Cite This Article

USTA, M., KESKİN, F., ERGÜVEN, M., İŞCAN, M., FEDAKAR, A., SALTIK, S., ÖCAL, S. (2022). Subacute sclerosing panencephalitis. Göztepe Tıp Dergisi, Cilt: 21 - Sayı: 1, 20–22. https://ajindex.com/articles/526327

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Esiri MM, Kennedy PGE: Virus Disease. Greenfields's Neuropathology'de. Ed. Adams JH, Duchen LW. Altıncı Baskı. Londra, Sid­ney, Auckland, Arnold 1997; Vol. II 39-42
  2. Dyken PR, Cuningham SC, Ward LC: Changing charecter of SSPE in US? Pediatric Neurology 5:339-341, 1989
  3. Hamilton RL, Wiley CA: Neuropathology of Viral infections of the Nervous System (Ch 17). Textbook of Neuropathology Ed. Davis RL, Robertson DM. 3. baskı, Baltimore, William-Wilkins, 1997, 984-988
  4. Zilber N, Kahana E: Environmental risk factor subacute sclerozing panencephalitis. Acta Neurol (Scan) 98:49-54, 1998
  5. Dyken PR, Maertens P: Viral infections. Pediatric Neuropathology. Ed: Duckett S. Baltimore, William-Wilkins 199-5, 403-422
  6. Dyken PR: Subacute sclerosing panencephalitis. Current status. Neurologic Clinics. Pediatric Neurology. Ed: Swaiman KF. Philadelphia, W.B. Saunders 1985
  7. Horta-Barbosa L, Fuccillo DA, Sever JL, Zeman W: Subacute sclerosing panencephalitis isola- tion of measles virus from a brain bi­opsy. Nature 221:974, 1969
  8. Connolly JH, Haire M, Hadden DSM: Measles immunoglobulins in subacute sclerosing pan-encephalitis. Br Med J Med J 1:23-25, 1971
  9. Sever JL: Persistent measles infectionof CNS: Subacute sclerosing panencephalitis. Rev. Infect Dis 5:467-473, 1983
  10. Sie TH, Weber W, Freling G, Galama J, Spaans F, Vies J: Ra­pidly fatal subacute sclerosing panencephalitis in a 19 year old man.Eur Neurol 31:94-99, 1991
  11. Dyken PR, SSPE: Current status. Neurol clinic 3:179-196, 1985
  12. Dyken PR, Swift A, Durrant RH: Long term follow up patients with subacute sclerosing panencephalitis treated with inosiplex Ann Neurol 11:359-364, 1982
  13. Anlar B, Yalaz K, İmir T, Turanlı G: The effect of inosiplex in subacute sclerosing panencephalitis: a clinical and labor. Study Eur Neurol 34:44-47, 1994.